Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Virchows Arch. 2018 Dec 12;474(3):365–374. doi: 10.1007/s00428-018-2497-8

Table 1.

Patient Characteristics

Patient No. Recipient Sex Donor Sex Recipient -Donor HLA status Preparation -Donor cell typea Age Diagnosis Pregnancies (sons) Days post-transplant Cause of death
1 Female Male Matched related BM 55 Myeloma 3 (3) 21 Diffuse alveolar damage, parainfluenza-3 pneumonia
2 Female Male Matched related PBSC 49 Myeloma ? (1) 48 Diffuse alveolar damage, hypertrophic cardiomyopathy
3 Female Male 1 Antigen MM related PBSC 56 Myeloma 4 (1) 87 Aspergillosis
4 Female Male 1 Antigen MM unrelated BM 39 CML ? (0) 172 Diffuse alveolar damage, varicella pneumonia
5 Female Female Matched unrelated BM 27 ALL 1 (0) 20 Fungal pneumonia
6 Female Female Matched unrelated BM 48 AML 2 (1) 36 Sinusoidal Obstruction Syndrome
7 Female Female Matched related BM 43 AML 3 (≥1) 68 Pseudomonas pneumonia
8 Female Female Matched related BM 39 RAEB 3 (≥1) 74 Aspergillosis, septicemia
9 Female Female Matched related PBSCb 63 DLCL 6 (≥1) 83 Aspergillus pneumonitis
10 Male Male Matched related BM 47 RAEB 83 Congenital heart disease, central leukodystrophy
a

All transplants were myeloablative, except where noted.

b

Nonmyeloablative.

BM bone marrow, PBSC peripheral blood stem cells, MM mismatched